Drugmaker Biogen had high hopes for its landmark Alzheimer’s medication Aduhelm. But ever since its controversial July 2021 approval by the Food and Drug…
Scientists have faced obstacle after obstacle in the search for effective Alzheimer’s drugs. While there are a number of symptomatic drugs approved by the…
Vaccines are considered one of the greatest innovations in medical history. Immunizations help train the body’s immune system to recognize and respond to a…
Biogen announced that the Food and Drug Administration (FDA) has updated the label for its anti-amyloid drug Aduhelm. These changes will add an additional…
Biogen has abandoned its application for the approval of anti-amyloid Alzheimer’s therapy Aduhelm (aducanumab) with European regulatory agencies. This marks yet another setback arises…
The FDA approves a new, transdermal form of donepezil called Adlarity, a skin patch for treating Alzheimer’s symptoms. Experts say it could be easier…
In February of this year, the Centers for Medicare and Medicaid Services (CMS) released a confusing proposal to dramatically limit insurance coverage for Aduhelm,…
I’m a 52-year-old pediatrician diagnosed with younger-onset Alzheimer’s disease in November 2020. Alzheimer’s is not my story, but now it’s my life. This is what…
The lack of effective treatments for Alzheimer’s have spurred scientists to rethink the dominant approach to tackling the disease: the amyloid hypothesis. This hypothesis…
“It’s been very confusing,” said Pam Montana, an advocate for Alzheimer’s who has participated in several clinical trials herself, adding that the recent memo…
Here’s how VOA’s 5 founders — including reporter Phil Gutis — responded to recent Aduhelm Medicare announcement. A few months ago, I received an…
Download this explainer as a PDF. The Alzheimer’s Association: Helped assemble a 2018 consortium that led to a biomarker-based definition of Alzheimer’s, controversial because…
Alzheimer’s is a notoriously difficult disease to identify with certainty. By the time a patient receives a diagnosis, its pathology in the brain is…
What’s the difference between treating Alzheimer’s symptoms and modifying the disease? Despite decades of research, the underlying cause of Alzheimer’s continues to evade scientists….
Biogen is slashing in half the price of its controversial drug Aduhelm, which was approved by the FDA in June as the first disease-modifying…